Here, we determined the transcriptional landscape of ER+ MCF7 palbociclib-sensitive (MCF7/pS) and palbociclib-resistant (MCF7/pR) breast cancer cells via next-generation transcriptomic RNA sequencing (RNA-seq). The gene discussed is ESR1; the disease is breast carcinoma.